ANGPT2 & VEGFA, Human, (Vanucizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-ANGPT2 & VEGFA, Human, (Vanucizumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityANGPT2 & VEGFA, Human, (Vanucizumab biosimilar)
CloneVanucizumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeVH-C kappa-CH2-CH3_V lambda-CH1_H-GAMMA-1_l kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsWB, FCM, IP, ELISA, Neut, FuncS, IF
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human ANGPT2 & VEGFA Recombinant Antibody (Vanucizumab). Vanucizumab (INN, development code RG7221) is an experimental humanized monoclonal antibody designed for the treatment of cancer.
Immunogenn/a
Other NamesAnti-ANGPT2 & VEGFA Recombinant Antibody, Research Grade Vanucizumab, Anti-Human ANGPT2 & VEGFA Recombinant Antibody(Vanucizumab), RG-7221, RG7221, RO5520985, Antibody Drug Analogues, Monoclonal Antibody, YR1341, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1448221-05-3
Catalog #YR1341
Priceplease inquire
Order / More InfoANGPT2 & VEGFA, Human, (Vanucizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.